Based on SEC filing data. A biotechnology corporation founded in 2014 and based in Seattle, WA raised $7.6M in Series A equity funding. The company is in the biotech sector.
Get notified the moment ApoGen Biotechnologies, Inc. files a new round, hires execs, or shows traction signals.
Create free accountAbout this data
FlareSight surfaces funding data from SEC Form D filings within hours of submission. Browse our full startup funding database to find more recently funded companies.